Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Cordis presta homenagem ao pioneiro da cardiologia Dr. José Eduardo Sousa

Cordis is a global interventional vascular technology company (PRNewsfoto/Cordis)

News provided by

Cordis

May 27, 2022, 09:00 ET

Share this article

Share toX

Share this article

Share toX

MIAMI LAKES, Flórida, 27 de maio de 2022 /PRNewswire/ -- A Cordis uniu-se à comunidade mundial de cardiologia para homenagear a memória de José Eduardo Sousa, MD, PhD que faleceu em 13 de março aos 88 anos.

Embora ele tenha contribuído com inúmeras realizações como médico inovador, seu compromisso de inspirar outras pessoas, compartilhar seu conhecimento e avançar silenciosamente o setor é lendário. 

Continue Reading
Cordis se une à comunidade mundial de cardiologia para homenagear a memória de José Eduardo Sousa, MD, PhD que faleceu em 13 de março aos 88 anos.
Cordis se une à comunidade mundial de cardiologia para homenagear a memória de José Eduardo Sousa, MD, PhD que faleceu em 13 de março aos 88 anos.

O Dr. José Eduardo Sousa formou-se na Universidade Federal de Pernambuco, em 1958, na Harvard Medical School, em 1963, e concluiu sua especialização em arteriografia coronária na Cleveland Clinic. Ele estabeleceu seu consultório em São Paulo e foi agraciado com uma família que incluiria outros três cardiologistas – sua esposa, Amanda Sousa, sua filha Andrea Abizaid e o genro, Alexandre Abizaid.

O Dr. José Eduardo Sousa é amplamente reconhecido por revolucionar o tratamento da doença arterial coronariana ao promover a prática de implante de stent. Ele realizou a primeira coronariografia no Brasil em 1966, tornou-se o primeiro cardiologista a implantar um stent Palmaz-Schatz em 1987 e utilizou pela primeira vez em humanos o stent farmacológico Cypher em 1999 com o Dr. Alexandre Abizaid e com o Dr. Patrick Serruys.

De 1983 a 2004, ele foi diretor técnico do Instituto Dante Pazzanese de Cardiologia em São Paulo, no Brasil.

Internacionalmente, o Dr. José Eduardo atuou como professor ilustre nas principais reuniões globais de cardiologia intervencionista, como TCT, EuroPCI e SCAI, e publicou mais de 550 artigos em revistas científicas como JACC e JACC: Interventions. Sua participação em mais de 120 projetos de pesquisa ajudou a moldar o campo da cardiologia intervencionista no presente.

"A cardiologia como a conhecemos hoje foi moldada por inovadores corajosos como o Dr. José Eduardo", disse Shar Matin, CEO da Cordis. "Todos neste setor, quer estejam há dez ou 50 anos, têm uma dívida com o Dr. José Eduardo Sousa. A Cordis teve a sorte de poder apoiar e colaborar com o Dr. José Eduardo ao longo de sua carreira. A criação do Cordis-X, um acelerador independente de desenvolvimento de produtos criado em 2021 para impulsionar novos dispositivos e tratamentos para a Cordis, teve inspiração em médicos pioneiros como o Dr. José Eduardo."

O Dr. José Eduardo Sousa dedicou grande parte de sua vida para estabelecer o Brasil como líder global em técnicas cardiológicas e foi o primeiro presidente da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, instituição de renome mundial que anunciou seu falecimento. Muitas homenagens de colegas do mundo todo lembraram do Dr. José Eduardo como um pioneiro, cavalheiro e inspiração para outras gerações de médicos.

"Imagine ser o primeiro médico a implantar um pedaço de metal na coronária de um paciente. Pense na coragem, no talento e na sabedoria que devem ter sido necessários em 1987", disse Matthew Muscari, presidente da Cordis nas Américas. "Tive o privilégio de encontrar vários colegas do Dr. José Eduardo no Brasil logo após seu falecimento. Nunca na minha vida vi um médico ser lembrado e homenageado com tanto carinho como ele foi. Foi excepcional."

O Dr. George Adams, CMO da Cordis, observou: "O Dr. José Eduardo Sousa pode ter representado apenas uma vida incrível, mas ele inspirou e capacitou uma comunidade global que salvou inúmeras vidas graças a seu trabalho. A capacidade de impactar o mundo, de salvar vidas em grande escala, é o que estimula este setor a nunca parar de inovar."

Sobre a Cordis

A Cordis é líder mundial no desenvolvimento e fabricação de tecnologias vasculares intervencionistas com uma história de mais de 60 anos de pioneirismo em tecnologias cardiovasculares revolucionárias para o tratamento de milhões de pacientes. Com uma reputação de competência clínica, treinamento e serviços, a Cordis estabeleceu um legado de inovação em produtos cardiovasculares de alta qualidade e menos invasivos e construiu uma sólida presença global com operações em mais de 60 países em todo o mundo.

Contato para a imprensa:

Margaret-Sarah Alexander
vice-presidente e diretora de marketing estratégico global
[email protected]
Cel.: 203-297-4182

Foto- https://mma.prnewswire.com/media/1826804/Jose_Sousa.jpg
Logotipo- https://mma.prnewswire.com/media/1676076/Cordis_Logo.jpg

FONTE Cordis

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Cordis Launches 10,000-Patient Global Coronary Registry for SELUTION SLR™ Drug-Eluting Balloon

Cordis Launches 10,000-Patient Global Coronary Registry for SELUTION SLR™ Drug-Eluting Balloon

Cordis, a global leader in interventional cardiovascular technologies, today announced the initiation of the SELUTION Global Coronary Registry. The...

Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR™ Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients

Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR™ Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients

Cordis, a global leader in interventional cardiovascular and endovascular technologies, announced new data from two major peripheral studies...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.